Auch interessant zum neuen Gerücht: Dr. Riedel sitzt im Vorstand von Jazz Pharmaceuticals, Ariad Pharmaceuticals und der Illinois Biotechnology Industry Organization…
Interesting - Dr. Norbert G. Riedel serves on the board for both Jazz and Ariad
Dr. Riedel serves on the boards of Jazz Pharmaceuticals, Ariad Pharmaceuticals and the Illinois Biotechnology Industry Organization. Look it up.
On the Cures Within Reach website...
Honoring Dr. Norbert G. Riedel with the Patient Impact Legacy Award (Read full press)
"I feel honored and humbled to be awarded this prestigious recognition. While major advances in science and medicine have enabled us to provide innovative therapies for critically ill patients, we need to continue to work together in our pursuit of finding cures for the many remaining diseases that impact the lives of patients around the world." - Dr. Riedel
Dr. Norbert Riedel is known and respected globally for his accomplishments in the pharmaceutical industry and his combination of scientific and business acumen. His significant contributions to the Midwest are apparent in his 15-years of service as corporate Vice President and Chief Science and Innovation Officer at Baxter International and his very recent appointment as Chief Executive Officer of Naurex, Inc. Naurex is a clinical-stage biopharmaceutical company developing products to treat diseases of the central nervous system (CNS).
Earlier in his tenure, Dr. Riedel was president and general manager of the recombinant proteins unit and vice president of research and development for Baxter's Bioscience business. Previously, Dr. Riedel was head of worldwide biotechnology and core research functions at Hoechst Marion Roussel, now Sanofi. He also held a number of scientific management positions at Hoechst-Marion Roussel and Hoechst. Dr. Riedel serves on the boards of Jazz Pharmaceuticals, Ariad Pharmaceuticals and the Illinois Biotechnology Industry Organization. Dr. Riedel is a member of the Austrian Academy of Sciences and was appointed by Governor Pat Quinn to serve on the Illinois Innovation Council. He is an adjunct professor of biochemistry and medicine at Boston University School of Medicine and adjunct professor of medicine at Northwestern University's Feinberg School of Medicine. Dr. Riedel received a Diploma and Ph.D. from the University of Frankfurt and was a postdoctoral fellow
finance.yahoo.com/mbview/threadview/...7&mbtc=mb-tab-topic
Zurück
